Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

All 12 studies were included in highest vs. lowest meta-analysis of the relationship between 25(OH)D level and risk of dementia.

Source: 25(OH)D level and risk of dementia. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

25-Hydroxyvitamin D Levels and the Risk of Dementia and Alzheimer's Disease: A Dose: Response Meta-Analysis

Source: Article title.

Publisher article type: systematic-review

Source: Publisher publication metadata.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

25-Hydroxyvitamin D Levels and the Risk of Dementia and Alzheimer's Disease: A Dose-Response Meta-Analysis

Review / evidence synthesis · Frontiers in Aging Neuroscience · 2018

Original publication title

25-Hydroxyvitamin D Levels and the Risk of Dementia and Alzheimer's Disease: A Dose: Response Meta-Analysis

Hanze Chen; Weishuang Xue; Jinwei Li; Kailei Fu; Han Shi; Beidi Zhang; Weiyu Teng; Li Tian

Copyright © 2018 Chen, Xue, Li, Fu, Shi, Zhang, Teng and Tian.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Conclusion:

Plasma or serum 25-hydroxyvitamin D concentration was inversely related to the risk of dementia and Alzheimer's disease, consistent with a linear dose: response relationship.

An extract from the source publication. Read it in context.

At a glance

Abstract: What methods does the paper describe?

Pubmed, Embase, Cochrane, and Web of Science databases were searched for relevant studies. Cohort studies concerning the association between 25-hydroxyvitamin D level and dementia or Alzheimer's disease were included. Results of studies were pooled and the dose: response relationship was determined using a random-effect model.

Source: Methods:

Abstract: Results

Ten cohort studies, with 28,640 participants were included. A significant inverse relationship was found between 25-hydroxyvitamin D level and the risk of dementia and Alzheimer's disease. In addition, we found a linear dose: response relationship in that a 10 nmol/L increase in 25-hydroxyvitamin D level may lead to a 5% decrease in the risk of dementia (relative risk, 0.95; 95% confidence interval, 0.93 to 0.98) and 7% in the risk of Alzheimer's disease (relative risk, 0.93; 95% confidence interval, 0.89 to 0.97).

Source: Results:

Abstract: Conclusion

Plasma or serum 25-hydroxyvitamin D concentration was inversely related to the risk of dementia and Alzheimer's disease, consistent with a linear dose: response relationship.

Source: Conclusion:
Authors’ abstract

Background and Purpose: Conclusions of previous cohort studies on the relationship between 25-hydroxyvitamin D level and the risk of dementia and Alzheimer's disease were not consistent. Thus, we performed a dose: response meta-analysis to evaluate this relationship by summarizing cohort studies.

Methods:

Pubmed, Embase, Cochrane, and Web of Science databases were searched for relevant studies. Cohort studies concerning the association between 25-hydroxyvitamin D level and dementia or Alzheimer's disease were included. Results of studies were pooled and the dose: response relationship was determined using a random-effect model.

Results:

Ten cohort studies, with 28,640 participants were included. A significant inverse relationship was found between 25-hydroxyvitamin D level and the risk of dementia and Alzheimer's disease. In addition, we found a linear dose: response relationship in that a 10 nmol/L increase in 25-hydroxyvitamin D level may lead to a 5% decrease in the risk of dementia (relative risk, 0.95; 95% confidence interval, 0.93 to 0.98) and 7% in the risk of Alzheimer's disease (relative risk, 0.93; 95% confidence interval, 0.89 to 0.97).

Conclusion:

Plasma or serum 25-hydroxyvitamin D concentration was inversely related to the risk of dementia and Alzheimer's disease, consistent with a linear dose: response relationship.

Publication and source details

Original title: 25-Hydroxyvitamin D Levels and the Risk of Dementia and Alzheimer's Disease: A Dose: Response Meta-Analysis

Hanze Chen; Weishuang Xue; Jinwei Li; Kailei Fu; Han Shi; Beidi Zhang; Weiyu Teng; Li Tian

Frontiers in Aging Neuroscience · 2018

Edited by: Christian Gonzalez-Billault, Universidad de Chile, Chile

Reviewed by: Yangmei Chen, Second Affiliated Hospital of Chongqing Medical University, China; Sakineh Shab-Bidar, Tehran University of Medical Sciences, Iran

*Correspondence: Weiyu Teng tengweiyucmu@sina.comLi Tian tianlicmu2@126.com
Copyright © 2018 Chen, Xue, Li, Fu, Shi, Zhang, Teng and Tian.2018Chen, Xue, Li, Fu, Shi, Zhang, Teng and Tianhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:51:33.122590+00:00

DOI: 10.3389/fnagi.2018.00368 · PMC6237859